HLN healthscope notes limited

Last year the company failed an attempt to sell its pathology...

  1. chris_qld
    242 Posts.
    clock Created with Sketch.
    11/03/13
    16:20
    Post #: 11523442
    Last year the company failed an attempt to sell its pathology business to raise $100 million. At the same time,it suffered heavy losses. Now they want to issue new subordinated notes. Does it ring the bell?
    HLN Price at posting: 0.0¢ Sentiment: None Disclosure: Not Held
    Likes Created with Sketch.  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS MTM Successful Uplisting Commences Trading on OTCQX Market in US
right-arrow Created with Sketch.
NEWS Drilling Commences at Leinster South Project in WA
right-arrow Created with Sketch.
NEWS More Outstanding Gallium Assay Results for Nimy at Block 3
right-arrow Created with Sketch.
NEWS R&D Tax Refund of $5.8M Received by Imugene to Support Clinical Development
right-arrow Created with Sketch.
NEWS Austral Resources to Acquire Rocklands to Transform North-West Queensland Copper
right-arrow Created with Sketch.
NEWS Listen: HotCopper Wire Podcast 016 – FY25 ended up not so bad... but Trump unpause is coming
right-arrow Created with Sketch.
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.